| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/13/2010 | US20100121046 Collecting and processing complex macromolecular mixtures |
| 05/13/2010 | US20100121045 Bis-modified bicyclic nucleic acid analogs |
| 05/13/2010 | US20100121042 Chimera botulinum toxin type e |
| 05/13/2010 | US20100121030 Antagonism or evasion of soluble cytokine receptors |
| 05/13/2010 | US20100120895 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/13/2010 | US20100120893 Compositions and Methods for Inhibiting Expression of Transthyretin |
| 05/13/2010 | US20100120690 Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same |
| 05/13/2010 | US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 05/13/2010 | US20100120681 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 05/13/2010 | US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy |
| 05/13/2010 | US20100120677 Activity of recombinant equine follicle stimulating hormone |
| 05/13/2010 | US20100120675 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof |
| 05/13/2010 | US20100120664 Modified coagulation factors with prolonged in vivo half-life |
| 05/13/2010 | US20100120634 Compatible display vector systems |
| 05/13/2010 | US20100120153 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 05/13/2010 | US20100120151 enables embryogenic tissue to be detected in vitro thus allows for early discading of non-embryonic tissue; antioxidant; inhibition or retardation of apoptotic processes; tablet or cream form as an antiaging agent; used in generating male sterile plants |
| 05/13/2010 | US20100120147 Antagonist of ligands and uses thereof |
| 05/13/2010 | US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 05/13/2010 | US20100120141 Screening methods for compounds that modulate the activity of G-protein coupled receptors |
| 05/13/2010 | US20100120125 Bacterial biomineralization of contaminants |
| 05/13/2010 | US20100120121 Process for typing of HCV isolates |
| 05/13/2010 | US20100120120 Haemocoagulase |
| 05/13/2010 | US20100120118 MRNA Interferase from Myxococcus Xanthus |
| 05/13/2010 | US20100120108 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 05/13/2010 | US20100120098 Transposon end compositions and methods for modifying nucleic acids |
| 05/13/2010 | US20100120092 Recombinant proteins and virus like particles comprising l and s polypeptides of avian hepadnaviridae and methods, nucleic acid constructs, vectors and host cells for producing same |
| 05/13/2010 | US20100120091 Subtilase variants |
| 05/13/2010 | US20100120052 Orotate Transporter Encoding Marker Genes |
| 05/13/2010 | US20100120045 Genetic variants useful for risk assessments of coronary artery disease and myocardial infarction |
| 05/13/2010 | US20100120044 Modified polynucleotides comprising ribose rings |
| 05/13/2010 | US20100120034 Methylation analysis of mate pairs |
| 05/13/2010 | US20100120032 Transgenic plant event detection |
| 05/13/2010 | US20100120029 Mutagenesis of aspergillus fungi and genes essential for growth |
| 05/13/2010 | US20100120028 Probe, probe set, probe-immobilized carrier, and genetic testing method |
| 05/13/2010 | US20100120022 useful as diagnostic markers of a variant-detectable disease; Nucleic Acid Testing; more sensitive and specific; sequence specific rather than epitope specific |
| 05/13/2010 | US20100119690 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
| 05/13/2010 | US20100119688 Increasing low light tolerance in plants |
| 05/13/2010 | US20100119656 Cloning, expression and use of acid lysophospholipases |
| 05/13/2010 | US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 05/13/2010 | US20100119556 Methods and compositions for modulating an immune response with immunogenic oligonucleotides |
| 05/13/2010 | US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines |
| 05/13/2010 | US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/13/2010 | US20100119536 Naturally Processed Measles Virus Peptides From Class II HLA Molecules |
| 05/13/2010 | US20100119533 Polynucleotides and Polypeptides Identified by IVIAT Screening and Methods of Use |
| 05/13/2010 | US20100119532 Composition comprising the N-terminal region of histone H2B of Leishmania - use thereof for inducing an immune response |
| 05/13/2010 | US20100119520 Monoclonal antibodies that neutralize anthrax toxins |
| 05/13/2010 | US20100119518 Target for breast cancer therapy and/or diagnosis |
| 05/13/2010 | US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/13/2010 | US20100119495 Human skin equivalents expressing exogenous polypeptides |
| 05/13/2010 | US20100119483 Peptide viral entry inhibitors |
| 05/13/2010 | US20100119477 Psm peptides as vaccine targets against methicillin-resistant staphylococcus |
| 05/13/2010 | US20100119446 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/12/2010 | EP2184369A1 Method for normalisation in electrophoresis |
| 05/12/2010 | EP2183388A2 Molecular redundant sequencing |
| 05/12/2010 | EP2183266A2 Modified nucleotides, methods for making and using same |
| 05/12/2010 | EP2002018B1 Antisense antiviral compound and method for treating arenavirus infection |
| 05/12/2010 | EP1706489B1 Oligomeric compounds for the modulation of bcl-2 |
| 05/12/2010 | EP1578772B1 Cytokines and cytokine receptors with reduced immunogenicity |
| 05/12/2010 | EP1412518B1 Sorting and immobilization system for nucleic acids using synthetic binding systems |
| 05/12/2010 | DE112008001507T5 Neue Hybridverbindungen von Nukleobasen und organischen Redox-Molekülen und ihre Verwendung New hybrid compounds of nucleobases and organic redox molecules and their use |
| 05/12/2010 | CN1837364B Real-time fluorescence PCR immobilization kit of wheat dwarf bunt germ (Tilletia controversa kuhn) and its detection method |
| 05/12/2010 | CN1753903B Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| 05/12/2010 | CN1715918B Configurable dynamic three dimensional array |
| 05/12/2010 | CN1671865B Microparticle based signal amplification method and its application in the detection of analytes |
| 05/12/2010 | CN1644686B High yielded strain of mammalia influenza virus, its recommbined strains and preparation and use thereof |
| 05/12/2010 | CN1590543B Thermostable Taq polymerase fragment |
| 05/12/2010 | CN101705224A Method for extracting genome from 'meat ganoderma lucidum' |
| 05/12/2010 | CN101130771B Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament |
| 05/12/2010 | CN101130768B Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament |
| 05/12/2010 | CN101011582B Medicament for emergency treatment after hydrophobia exposition and emergency therapy at early stage of pathogenesis, and its preparing process |
| 05/11/2010 | USRE41327 detection of nucleic acid derived from mutant oncogenes or other tumor-associated DNA; detection, identification, or monitoring of the existence, progression or clinical status of neoplasia in humans or other animals that contain a mutation that is associated with the neoplasm |
| 05/11/2010 | US7715990 Probe correction for gene expression level detection |
| 05/11/2010 | US7715989 Systems and methods for predicting oligonucleotide melting temperature (TmS) |
| 05/11/2010 | US7714216 Plants and seeds of hybrid corn variety CH491400 |
| 05/11/2010 | US7714207 Inbred corn line LEP20 |
| 05/11/2010 | US7714206 Inbred corn line LLR24 |
| 05/11/2010 | US7714204 Inbred corn line 5RQ675 |
| 05/11/2010 | US7714203 Inbred corn line BE9513 |
| 05/11/2010 | US7714192 Poplar transcription factors |
| 05/11/2010 | US7714187 Phytate polynucleotides and methods of use |
| 05/11/2010 | US7714185 introducing nucleic acids into said organism which code for polypeptides having acyl-CoA: lysophospholipid-acyltransferase for enhancing production of dihmo-gama-linolenic, arachidonic, eisosapentaenoic, docosapentaenoic acid and/or docosahexaenoic acids |
| 05/11/2010 | US7714122 kits for detecting the presence of an enterovirus (EV) RNA sequence in a sample using enterovirus-specific primers, diagnosing an EV infection in a subject |
| 05/11/2010 | US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein |
| 05/11/2010 | US7714120 Humanized anti-IL-1 beta antibodies |
| 05/11/2010 | US7714119 AAV vector compositions and methods for enhanced expression of immunoglobulins using the same |
| 05/11/2010 | US7714117 nucleic acid encoding polypeptides that are used as biomarkers for identifying algae species and strains of algae species as well as detect the presence of algal toxins |
| 05/11/2010 | US7714102 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors; treatment of cancer and bone growth |
| 05/11/2010 | US7713944 Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells |
| 05/11/2010 | US7713943 as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target |
| 05/11/2010 | US7713738 Oligomeric compounds for the modulation of survivin expression |
| 05/11/2010 | US7713737 delivery construct, comprising a receptor binding domain, a transcytosis domain, a macromolecule to be delivered to a subject, and a cleavable linker |
| 05/11/2010 | US7713735 Gene silencing |
| 05/11/2010 | US7713724 Hydantoin racemase |
| 05/11/2010 | US7713722 inexpensive and simple method which allows efficient glycosylation with glycosyltransferases derived from microorganisms of the Vibrionaceae family; contacting the sialyltransferase with a glycosyl donor substrate and a glycosyl acceptor substrate in the presence of 0.1 M-2.0 M NaCl |
| 05/11/2010 | US7713718 introducing DNA containing the sequence coding for an alpha subunit, which has a glucose dehydrogenase activity, and a beta subunit that is an electron-transfer protein, into a microorganism belonging to the genus Pseudomonas to obtain in a transformant; used in a glucose sensor |
| 05/11/2010 | US7713702 Biomarkers for diagnosing schizophrenia and bipolar disorder |
| 05/11/2010 | US7713701 DNA-binding polymers |
| 05/11/2010 | US7713698 Determining sequence of preferential DNA sequences |
| 05/11/2010 | US7713694 Method of enhancing fluorescence |
| 05/11/2010 | US7713634 Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same |